Eliminate Data Silos with One Digital Platform.
▹ Orchestrate + Automate Processes. Unify Data.
▹ Cut Lead-Times. Reduce Operational Costs.
▹ Accelerate Science with AI-Ready Data.
L7 IS A DELOITTE FAST 500 COMPANY
We’ve been listed in the Deloitte Fast 500 annual ranking of fastest-growing companies for the 4th consecutive year – what an honor!
data silos are costing you more than you think
Data silos aren’t just slowing you down—they’re silently draining your time, your budget, and your competitive edge.
Most life sciences organizations are built on fragmented systems, each with its own language, logic, and limits. The result? Disconnected workflows, unstructured data, and innovation stuck in first gear.
AI won’t help you—unless you fix your data first
Everyone’s racing to implement AI—but without the right data foundation, most efforts fall flat. At the same time, drug development is taking longer and costing more than ever before. Disconnected systems, fragmented workflows, and inaccessible data are delaying therapies, driving up costs, and keeping companies from reaching AI’s full potential.
10 years
On average, that’s how long it takes to deliver new treatments, with inefficiencies dragging out every phase.*
$2.3B+
The cost of bringing a new drug to market is soaring, putting strain on R&D and manufacturing.**
<25% AI-readiness
Most companies aren’t yet in a position to leverage AI at scale.*
unify, contextualize, orchestrate—L7|ESP powers AI-driven science
AI is only as powerful as the data behind it. But in life sciences, silos, inconsistent ontologies, and fragmented systems create an AI chasm—blocking the path to real value. That’s where L7|ESP comes in. Our composable platform contextualizes data at the source, automates end-to-end processes, and standardizes workflows across research, development, and manufacturing—eliminating silos and laying the groundwork for real AI readiness.
L7|ESP isn’t just a platform—it’s your digital backbone. With modular components like L7|MASTER, L7|HUB, L7|ESP CORE, and L7|INTELLIGENCE, it powers AI-ready data, seamless orchestration, and cross-functional collaboration at every stage of your digital journey.
And the best part? L7|ESP layers over your existing systems—no disruptive rip-and-replace required.
why digital-first life sciences teams trust L7|ESP
Unifying Platform
L7|ESP connects and orchestrates lab and manufacturing workflows, eliminating silos and ensuring AI-ready data at the source.
- Seamless integration – Works with instruments, equipment, and legacy systems.
- Data contextualization – Captures data at the point of generation, eliminating complex downstream transformations.
- Reduced IT overhead – Minimizes manual intervention and simplifies data management.
- Real-time insights – Transforms raw data into actionable intelligence without degradation over time.
- Adaptable in any IT landscape – Supports both legacy-heavy (brownfield) and newly established (greenfield) environments.
- More than a data lake – A fully
u nifying platform with built-in LIMS, ELN, MES, Scheduling apps , and more.
Compliance + AI-Ready
L7|ESP ensures data integrity, traceability, and AI readiness by structuring information at the point of execution.
- Complete audit trail – Captures instruments, reagents, media, and personnel for every experiment or process.
- Automatic data contextualization – Eliminates the need for complex ETL pipelines and siloed storage.
- AI-ready foundation – Organizes data for seamless AI/ML training, including LLMs.
- Enhanced regulatory compliance – Simplifies audits, submissions, and root cause analysis.
- Single source of truth – Ensures structured, intact, and contextualized data for improved decision-making.
Rapid Tech Transfers
L7|ESP streamlines internal and external tech transfers, accelerating time-to-market for drug products, biologics, and diagnostics.
- Seamless digital transfers – Eliminates process variations and the need to revert to paper.
- Unified data + processes – Ensures consistency across research, development, clinical trials, and commercialization.
- gxP-compliant – Maintains data integrity and harmonization throughout the product lifecycle.
- CRO/CDMO-ready – Enables smooth collaboration with external partners.
- Faster scale-up + commercialization – Reduces delays and inefficiencies in tech transfer.
Portfolio Optimization
L7|ESP simplifies IT ecosystems, reducing costs and freeing resources for innovation.
- Eliminates redundancies – Orchestrates interactions across legacy systems, instruments, and equipment.
- Reduces IT complexity – Streamlines architecture to optimize resource allocation.
- Future-proof framework – Supports both monolithic and next-gen solutions.
- Phased system transitions – Enables seamless onboarding and retirement of technologies.
- Unlocks AI + ML potential – Frees budgets for transformative technologies like Gen
AI , machine learning, and Agentic AI.
Operational Excellence
L7|ESP unifies research, lab, and manufacturing operations, eliminating inefficiencies and enhancing visibility
- End-to-end integration – Connects ELN, LIMS, MES, and Scheduling in a single platform.
- Optimized workflows – Replaces paper-based processes to improve efficiency.
- Material + capacity management – Ensures better resource utilization.
- Real-time operational insights – Provides answers to critical questions on test timelines, batch delays, and resource allocation.
- Smarter decision-making – Enhances visibility across Research, Development, and Manufacturing.
L7 | CHATS
Top 5 Reasons Tech Transfer Keeps Breaking… And What We...
Tech transfer in life sciences is plagued by delays, misalignments, and costly failures. In this thought leadership article, Teodor Leahu
Beyond Consolidation: Why Orchestration is the Real ROI Multiplier in...
McKinsey estimates that consolidating software and migrating to the cloud can reduce R&D IT spend by up to 30%. But
Gartner’s 2025 Vision for LIMS is Clear… and L7 has...
Gartner’s latest Market Guide for LIMS defines the future: a digital unified platform powering the lab of the future. But
Q&A with Marcia Blackmoore | Building Smarter, Faster CDMOs: A...
In this Contract Pharma Q&A, Marcia Blackmoore, VP of Customer Ops at L7, explains why a data-first approach is essential
meet us at
latest news
Bioprocess Online: Keep An Eye On These Analytical And Monitoring...
Caraugh Albany, Charlie Wakeham, and Steven Erb weigh in on the upcoming industry advancements for 2025 in this Bioprocess Online
Outsourced Pharma: Keep An Eye On These Analytical And Monitoring...
Outsourced Pharma features industry leaders Caraugh Albany, Charlie Wakeham, and Steven Erb as they share their thoughts on how the
Biosimilar Development: Keep An Eye On These Analytical And Monitoring...
In this Biosimilar Development, industry leaders Caraugh Albany, Charlie Wakeham, and Steven Erb discuss their insights on how advancements in
Life Sciences’ Need for AI-Ready Data and Unifying Platform Places...
For the fourth year running, L7 has earned a spot on the Deloitte FAST 500 list, and we couldn't be
recent case studies
Case Study: Supporting Cellipont Bioservices in Their Mission to Advance...
L7|ESP, with L7 MES, brings organizational excellence and efficiency to Cellipont’s cell and gene therapy processes by digitalizing and centralizing
Case Study: From Bottlenecks to Breakthroughs: L7|ESP® Supercharges Top Pharma’s...
L7|ESP helped a global pharma leader streamline biosample management, enhance data integrity, and accelerate clinical trials—ensuring faster, more compliant, and
Case Study: Supporting The Jackson Laboratory’s Need to Increase Connectivity...
L7|ESP brought organization and efficiency – 80% of their time compared to the legacy manual process - to The Jackson
Case Study: Supporting Alpine Bio in Their Mission to Transform...
L7|ESP brought consistency and efficiency to the Alpine Bio research processes – a 50% increase in sample throughput compared to
